Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_308ab73b3610373b586db1bb1be0dd08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 |
filingDate |
2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6d39725193aae77f1f65f35bc0c557 |
publicationDate |
2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7767686-B2 |
titleOfInvention |
Method of using adenosine receptor blockers during tissue ablation |
abstract |
A mammal undergoing an ablation procedure is treated for symptoms associated with adenosine by administering one or more adenosine receptor antagonists to the mammal prior to or during the procedure. |
priorityDate |
2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |